Kuros Biosciences AG (KURN):企業の財務・戦略的SWOT分析

◆英語タイトル:Kuros Biosciences AG (KURN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81908FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Kuros Biosciences AG (KURN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Kuros Biosciences AG (Kuros Biosciences) is a developer of products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specifically fracture repair, as well as on spinal fusion. Its pipeline of products are being developed for spinal fusion, fracture repair and as surgical sealants. Kuros Biosciences uses a synthetic matrix technology with reliable and pressure resistant, rapid closure of the damaged tissues. The company’s lead sealant product is Neuroseal. The company operates in Schlieren, Switzerland; Bilthoven, the Netherlands; Burlington, USA and in Konstanz, Germany. Kuros Biosciences is headquartered in Schlieren, Switzerland.

Kuros Biosciences AG Key Recent Developments

Aug 12,2020: Kuros Biosciences reports results for first half 2020
Mar 26,2020: Kuros Biosciences reports results for the full year 2019
Dec 03,2019: Kuros announces final result of Capital Increase – total gross proceeds of CHF 12.5 million raised
Aug 20,2019: Kuros Biosciences reports results for first half 2019
Jul 24,2019: Kuros announces Gerhard Ries is stepping down as Board member

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Kuros Biosciences AG – Key Facts
Kuros Biosciences AG – Key Employees
Kuros Biosciences AG – Key Employee Biographies
Kuros Biosciences AG – Major Products and Services
Kuros Biosciences AG – History
Kuros Biosciences AG – Company Statement
Kuros Biosciences AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Kuros Biosciences AG – Business Description
Geographical Segment: Other
Performance
Geographical Segment: United Kingdom
Performance
Geographical Segment: United States of America
Performance
Kuros Biosciences AG – SWOT Analysis
SWOT Analysis – Overview
Kuros Biosciences AG – Strengths
Kuros Biosciences AG – Weaknesses
Kuros Biosciences AG – Opportunities
Kuros Biosciences AG – Threats
Kuros Biosciences AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Kuros Biosciences AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 12, 2020: Kuros Biosciences reports results for first half 2020
Mar 26, 2020: Kuros Biosciences reports results for the full year 2019
Dec 03, 2019: Kuros announces final result of Capital Increase – total gross proceeds of CHF 12.5 million raised
Aug 20, 2019: Kuros Biosciences reports results for first half 2019
Jul 24, 2019: Kuros announces Gerhard Ries is stepping down as Board member
Apr 30, 2019: Kuros Biosciences to propose re-appointment of chairman and board members at Annual General Meeting
Apr 12, 2019: Kuros Biosciences reports results for the full year 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Kuros Biosciences AG, Key Facts
Kuros Biosciences AG, Key Employees
Kuros Biosciences AG, Key Employee Biographies
Kuros Biosciences AG, Major Products and Services
Kuros Biosciences AG, History
Kuros Biosciences AG, Subsidiaries
Kuros Biosciences AG, Key Competitors
Kuros Biosciences AG, Ratios based on current share price
Kuros Biosciences AG, Annual Ratios
Kuros Biosciences AG, Annual Ratios (Cont...1)
Kuros Biosciences AG, Interim Ratios
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Kuros Biosciences AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Kuros Biosciences AG (KURN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Evoke Pharma Inc (EVOK):企業の財務・戦略的SWOT分析
    Summary Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases. The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. It also offers solutions fo …
  • Cheniere Energy Inc (LNG):企業の財務・戦略的SWOT分析
    Cheniere Energy Inc (LNG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Metalico Inc:企業の戦略的SWOT分析
    Metalico Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • GoPro, Inc.:戦略・SWOT・企業財務分析
    GoPro, Inc. - Strategy, SWOT and Corporate Finance Report Summary GoPro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sanford Burnham Prebys Medical Discovery Institute-製薬・医療分野:企業M&A・提携分析
    Summary Sanford Burnham Prebys Medical Discovery Institute (Sanford Burnham) is a non-profit public benefit institute that offers medical research services. The institute offers research programs in the field of tumor initiation and maintenance, cancer metabolism and signaling networks, tumor microe …
  • Theravasc Inc-製薬・医療分野:企業M&A・提携分析
    Summary Theravasc Inc (Theravasc) is a healthcare services provider that develops treatments for various chronic medical diseases using oral formulation of sodium nitrite. The company’s product TV1001SR is a coated oral formulation of sodium nitrite for the treatment of peripheral artery diseases an …
  • Proteon Therapeutics Inc (PRTO):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteon Therapeutics Inc (Proteon Therapeutics) is a late-stage biopharmaceutical company that develops pharmaceutical products for the treatment of renal and vascular diseases. The company develops investigational therapies to treat hemodialysis and peripheral artery disease patients. Its p …
  • NEC Networks & System Integration Corp (1973):企業の財務・戦略的SWOT分析
    NEC Networks & System Integration Corp (1973) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Tennessee Valley Authority:企業の発電所・SWOT分析2018
    Tennessee Valley Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Stamps com Inc (STMP):企業の財務・戦略的SWOT分析
    Stamps com Inc (STMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Centene Corp (CNC):企業の財務・戦略的SWOT分析
    Centene Corp (CNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Centrica Plc (CNA):電力:M&Aディール及び事業提携情報
    Summary Centrica Plc (Centrica) is an integrated energy company. It carries out electricity generation through and combined cycle gas turbine (CCGT) power stations, and nuclear power plants through its stake in EDF Energy Nuclear Generation. Centrica secures and supply gas and electricity to homes a …
  • Precision Drilling Corp (PD):石油・ガス:M&Aディール及び事業提携情報
    Summary Precision Drilling Corp (Precision) is a provider of onshore drilling and production services to exploration and production companies in the oil and natural gas industry. It offers contract drilling, well servicing and other support services to oil and natural gas exploration and production …
  • Indiana University Research & Technology Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Indiana University Research & Technology Corp (IURTC), a subsidiary of Indiana University, is a non-profit company that handles intellectual property, trademarks, and business development activities. The company offers solutions such as technology commercialization, which include disclosure, …
  • Archroma Pakistan Ltd. (ARPL):企業の財務・戦略的SWOT分析
    Archroma Pakistan Ltd. (ARPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Numedii Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Numedii Inc (Numedii) is a life science technology company that discovers and develops new drug candidates by translating life sciences big data into therapies. The company uses life sciences big data technology to discover and de-risk molecular entities based on therapeutically relevant bio …
  • Emergent BioSolutions Inc (EBS):医療機器:M&Aディール及び事業提携情報
    Summary Emergent BioSolutions Inc (Emergent) is a life sciences company. It focuses on protecting and enhancing life by providing specialized products to governments and healthcare providers. The company develops specialty products targeting public health threats and emerging infectious diseases. It …
  • Grifols SA (GRF)-製薬・医療分野:企業M&A・提携分析
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • Empresa Nacional de Hidrocarbonetos EP:石油・ガス:M&Aディール及び事業提携情報
    Summary Empresa Nacional de Hidrocarbonetos EP (ENH) is an oil and gas company that explores, produces and markets petroleum products. The company conducts research, exploitation, production, refining, transportation, storage and marketing of hydrocarbons and its derivatives such as liquefied natura …
  • Equifax Inc.:企業の戦略・SWOT・財務情報
    Equifax Inc. - Strategy, SWOT and Corporate Finance Report Summary Equifax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆